Research Article
Primary Gastric Lymphoma: Conservative Treatment Modality Is Not Inferior to Surgery for Early-Stage Disease
Table 4
The clinical variables and their prognostic impact on five-year DFS and OS.
| | | DFS (%) | valuea | OS (%) | valuea |
| Gender | Female | 76.4 | 0.7 | 84.1 | 0.6 | Male | 81.2 | 81.9 | Age | >60 | 77.9 | 0.4 | 75.5 | 0.04 | ≤60 | 79.9 | 89.8 | LDH | >240 mg | 72.5 | 0.007 | 79.9 | 0.09 | Normal range | 86.8 | 90.9 | Symptoms | B symptoms present | 82.3 | 0.4 | 79.2 | 0.2 | B symptoms absent | 74 | 88.6 | Lymphoma subtype | MALT | 81.3 | 0.57 | 91.2 | 0.38 | Non-MALT | 76.9 | 81.2 | Karnofsky index | ≥80 | 89.5 | 0.002 | 89.5 | 0.002 | <80 | 54.5 | 63.6 | Stage | I/II, IIE | 83.9 | 0.02 | 91.2 | 0.002 | IV | 65.5 | 70.6 | Treatment (for stage I/II, IIE) | Surgery | 85.7 | 0.18 | 86.5 | 0.8 | Conservative | 82.1 | 94 |
|
|
aLong-rank test. DFS: disease-free survival, OS: overall survival, LDH: lactate dehydrogenase, and MALT: mucosa associated lymphoid tissue.
|